BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Endo International Provides Informational Frequently Asked Questions & Answers

  November 9, 2015

   · 

  1 min read
• Drug Development

  Eli Lilly And Incyte Announce Patients Treated With Baricitinib Demonstrated Significant Improvement In Signs And Symptoms Of Rheumatoid Arthritis Compared With Methotrexate

  November 9, 2015

   · 

  9 min read
• Drug Development

  Amgen Presents Detailed Data Comparing Etelcalcetide With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

  November 9, 2015

   · 

  14 min read
• Drug Development

  Nutramax Laboratories Release; New Clinical Evidence Finds Chondroitin Sulfate Superior To Celecoxib At Reducing Cartilage Loss In Knee Osteoarthritis

  November 9, 2015

   · 

  4 min read
• Pfizer Canada Inc. Release: Update on Availability Of EpiPen (epinephrine) Auto-Injectors For Canadian Patients

  November 9, 2015

   · 

  2 min read
• Drug Development

  Eli Lilly Release: Detailed Results Demonstrate Baricitinib Superiority To Adalimumab In Improving Signs And Symptoms Of Rheumatoid Arthritis

  November 9, 2015

   · 

  9 min read
• Pharm Country

  Boehringer Ingelheim Highlights Latest Community And Research Initiatives In Advancing Anticoagulation Care At American Heart Association Scientific Sessions 2015

  November 9, 2015

   · 

  5 min read
• Drug Development

  Immune Pharma Announces FDA Acceptance Of Investigational New Drug (IND) Application In The U.S. For Bertilimumab For The Treatment Of Bullous Pemphigoid

  November 9, 2015

   · 

  6 min read
• Drug Development

  Akebia Therapeutics, Inc. Announces Presentation of Vadadustat Phase II Dialysis Data at American Society of Nephrology Kidney Week 2015 Annual Meeting

  November 9, 2015

   · 

  7 min read
• Drug Development

  Upsher-Smith Laboratories Release: Data Published In Epilepsia Shows USL261 (Intranasal Midazolam) Demonstrated A Promising Pharmacokinetic Profile, Including Increased Relative Bioavailability, When Compared With Injectable Midazolam Administered Intrana

  November 9, 2015

   · 

  5 min read